Brendan Smith

Stock Analyst at TD Cowen

(2.34)
# 2,559
Out of 4,918 analysts
6
Total ratings
60%
Success rate
10.25%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Brendan Smith

Ginkgo Bioworks Holdings
Sep 20, 2024
Maintains: Buy
Price Target: $3$10
Current: $12.19
Upside: -17.97%
Halozyme Therapeutics
Aug 7, 2024
Maintains: Buy
Price Target: $59$65
Current: $59.02
Upside: +10.13%
Novavax
May 13, 2024
Maintains: Hold
Price Target: $5$10
Current: $6.56
Upside: +52.44%
Arrowhead Pharmaceuticals
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $15.93
Upside: -
Denali Therapeutics
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $13.44
Upside: -